Abstract
Within human plasma, apolipoprotein B exists as two antigenically-related isoproteins, designated apoB- 100 (Mr 512,000) and apoB-48 (Mr 250,000). The major apoB secreted in vitro by normal human hepatocytes and Hep G-2 cells is apoB-100 (Edge, et al., 1985). The peripheral metabolism of VLDL and apoB in part determine the level of circulating LDL (Dolphin, 1985). The LDL, possesing apoB-100 as the principal apolipoprotein constituent, are the major cholesterol transporting lipoproteins in human plasma. Since both LDLcholesterol (Grundy, 1986) and apoB-100 (Brunzell et al., 1984) levels are directly and positively correlated with premature coronary artery heart disease, an understanding of the control of hepatic apoB-100 synthesis and secretion is important. The human apolipoproteins have been demonstrated to undergo several co-translational and post-translational modifications including proteolytic cleavage (Gordon et al., 1983; Stoffel et al., 1983; Zannis et al, 1983; Bojanovski et al., 1984), glycosylation (Swaminathan and Aladjem, 1976; Lee and Breckenridge, 1967; Brewer et al., 1974; Zannis and Breslow, 1981), covalent phospholyration (Beg et al., 1989; Davis et al., 1984; Sparks et al., 1988 and Jackson et al., 1990), fatty acid acylation (Hoeg et al., 1986 and Hoeg et al., 1988) and deamidation (Ghisseli et al., 1985). These structural alterations may have important physiologic as well as pathologic roles.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Allan, D., P. Thomas, and R. H. Michell. 1978. Rapid transbilayer diffusion of 1,2-diacylglycerol and its relevence to control of membrane curvature. Nature (london) 276: 289–290.
Beg, Z. H., J. A. Stonik, J. M. Hoeg, S. J. Demosky, Jr., T. Fairwell, and H. B. Brewer, Jr. 1989 Human apolipoprotein A-I: Post-translational modification by covalent phosphorylation, J. Biol. Chem. 264: 6913–6921.
Beg, Z. H., J. A. Stonik, and H. B. Brewer, Jr. 1987. Phosphorylation and modulation of enzyme activity of nature and 2rotease cleaved purified hepatic 3-hydroxy-3methylglutaryl coenzyme A reductase by a calcium/calmodulin-dependent kinase. J. Biol. Chem. 262: 13228–13240.
Bojanovski, D., R. E. Gregg, and H. B. Brewer, Jr. 1984. Tangier disease: in vitro conversion of proapoA-I Tangier to mature apoA-I Tangier. J. Biol. Chem. 259: 6049–6051.
Bradford, M. M. 1976. A rapid and sensitive methods for the quantitation of microgram quantities of protein utilizing thr principle of protein-dye binding.Anal.Biochem. 72: 248–254.
Brandt, H. Z. L. Capulong, and E.Y.C. Lee. 1975. Purification and properties of rabbit liver phosphorylase phosphatase. 250: 8038–8044.
Brewer, H. B., Jr., R.Shulman, P.Herbert, R.Ronan, and K. Wehrly. 1974. The complete amino acid sequence of alanine apolipoprotein (apoC-III), an apolipoprotein from human plasma very low density lipoproteins.J.Biol. Chem. 249: 4975–4984.
Brewer,H. B. Jr. 1981. Current concepts of molecular structure and metabolism of human apolipoproteins and lipoproteins. Klin. Wochschr. 59: 1023–1035.
Brunzell, J.D.A.D. Sniderman, J.J. Albers, and P.O. Kwiterovich, Jr. 1984. Apoprotein B and Al and coronary artery disease in humans.Arteriosclerosis 4: 79–83.
Cardin, A.D., K. R. Witt, J. Chao, H. S. Margolius, V. H. Donaldson, and R. L. Jackson. 1984. Degradation of apolipoprotein B-100 of human plasma low density lipoproteins by tissue and plasma kallikreins. J.Biol. Chem. 259: 8522–8528.
Capasso, J. M., T. W. Keenan, C. Aberjon, and C. B. Hirschberg. 1989. Mechanism of phosphorylation in the lumen of the Golgi apparatus: translocation of adenosine 5’-triphosphate in to Golgi vesicles from rat and mammary gland. J. Biol. Chem. 264: 5233–5240.
Cohen,P. 1985. Thr role of protein phosphorylation in the hormonal control of enzyme activity. Eur.J. Biochem. 151: 439–448.
Davis, R.A., G.M.Clinton, R.A.Borchardt, M.MaloneMcNeal, T.Tan, and G.R. Lattier. 1984. Intrahepatic assembly of very low density lipopoproteins: phosphorylation of small molecular weight apolipoprotein B.J.Chem. 259: 3383–3386.
Dolphin, P.J. 1985. Lipoprotein metabolism and the role of apolipoproteins as metabolic programmers.Can. J. Biochem.Cell Biol. 63: 850–869.
Edge, S.B., J.M.Hoeg, P.D.Schneider, and H.B.Brewer, Jr. 1985. Apolipoprotein B synthesis in man: liver synthesizes only apolipoprotein B-100. Metabolism. 34: 726–730.
Engstrom, L., U. Zetterqvist, U. Ragnorson, P. Ekman, and U.Dahlqvist- Edberg. 1982. Cell function and diffrentiation, pp. 203–212. Alan R. Liss, New York.
Ghisseli, G., M. F. Rohde, S. Tanenbaum, S. Krishnan, and A. M.Gotto. 1985. Origin of apolipoprotein A-I polymorphism in plasma. J. Biol. Chem. 29: 15662–15668.
Gordon, J. I., H. F. Sims, S. R. Lentz, C. Edelstein, A. M. Scanu, and A. W. Strauss. 1983. Proteolytic processing of human preproapolipoprotein A-I: a proposed defect in the conversion of proA-I to A-I in Tangier’s disease. J. Biol. Chem. 258: 4037–4044.
Grundy, S. M. 1986. Cholestrol and coronary heart disease. JAMA (J. Am. Med. Assoc.) 256: 2849–2858. Gofman, J. W., F. Glazier, A. Tomplin, B. Strisower, and O. De Lalla. 1954. Lipoproteins, coronary heart disease, and atherosclerosis. Physiol. Rev. 34: 589–607.
Havel, R. J., H. A. Eder, and J. H. Bragdon. 1955. The distribution and chemical composition of ultracentrifugally seperated lipoproteins in human serum. J. Clin. Invest. 34: 1345–1353.
Hoeg, J. M., M. S. Meng, R. Ronan, T. Fairwell, and H. B. Brewer, Jr. 1986. Human apolipoprotein A-I: post-translational modification by atty acid acylation. J. Biol. Chem. 261: 3911–3914.
Hoeg, J. M., M. S. Meng, R. Ronan, S. J. demosky, Jr., T. Fairwell, and H. B. Brewer, Jr. 1988. apolipoprotein B synthesized by Hep G-2 cells undergoes fatty acid acylation. J. Lipid. Res. 29: 1215–1220
Hughes, T. E., J. M. Ordovas, and E. J. Schaefer. 1988. Regulation of apoliproteinB synthesis and secretion by caco-2 cells: lack of fatty acid effects and control by intracellular calcium ion. J. Biol. Chem. 263: 3425–3431.
Hunter, T., and B. M. Sefton. 1980. Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proc. Natl. Acad. Sci. U.S.A. 77: 1311–1315.
Jackson, T. K., A. I. Salhamck, J. Elovson, M. L. Diechman, and J. M. Amatruda. 1990. Insulin regulates apolipoprotein B turnover and phosphorylation in rat hepatocytes. J. Clin. Invest. 86: 1746–1751.
Kaibuchi, K., Y. Takai, M. Sawamura, M. Hoshijima, T. Fujikura, and Y. Nishizuka. 1983. Synergistic functions of protein phosphorylation and calcium mobilization in platelet activation. J. Biol. Chem. 258: 6701–6704.
Knott, T. J., S. C. Rall, Jr., T. L. Innerarity, S. F. Jacobson, M. S. Urdea, Levy-Wilson, L. M. Bog Powell, R. J. Pease, R. Eddy, H. Nakai, M. Byers, L. M. Priestly, E. Robertson, L. B. Rall, C. Betsholtz, T. B. Shows, R. W. Mahley, and J. Scott. 1985. Human apolipoprotein B: structure of carboxyl-terminal domains, sites of gene expression, and chromosomal localization. Science 230: 37–43.
Knowles, B. B., C. C. Howe, and D. P. Aden. 1980. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science. 209: 497–499.
Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London). 227: 680–685.
Lee, P., and W. C. Breckenridge. 1967. The carbohydrate composition of human apo low density lipopoprotein from normal and type II hyperlipoproteinemic subjects. Can. J. Biochem. 52: 42–49.
Mendez, A. J., J. F. Oram, and E. L. Bierman. 1991. Protein kinase C as a modulator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol J. Biol. Chem. 266: 10104–10111.
Muller, D., and H. Holzer. 1981. Regulation of fructose-1,6- Disphosphatase in yeast by phosphryla-tionldephosphorylation. Biochem.Biophys. Res. Commun. 103: 926–933.
Osborne, J. C., and H. B. Brewer, Jr. 1977. The plasma lipoproteins. Adv. Protein Chem, 31: 253–337.
Parker, R. A., S. J. Miller, and D. M. Gibson. 1984. Phosphorylation of microsomal HMG-CoA reductase increases susceptibility to proteolytic degradaion in vitro. Biochem. Biophys. Res. Commun. 125: 629–635.
Parker, R. A., S. J. Miller, and D. M. Gibson. 1989. Phosphorylation Of native 97-kDa 3-hydroxy-3-methylglutaryl coenzyme A reductase from Rat liver: impact on activity and degradation of the enzyme. J. Biol. Chem. 264: 4877–4887.
Pontremoli, S., E. Melloni, M. Michetti, B. Sparatore, F. Salamino, O.Sacco, and B. L. Horecker, 1987. Phosphorylation and proteolytic modification of specific cytoskeletal proteins in human neutrophils stimulated by phorbol 12-myristate 13- acetate. Proc. Natl. Acad. Sci. USA. 84: 3604–3608.
Powell, M. A., and J. R. Glenrey. 1987. Regulation of calpactin I phospholipid binding by calpactin I light chain binding and phospho-rylation by P60“ re. Biochem. J. 247: 321–328.
Sato, R. T. Imanaka, A. Takatsuki, and T. Takano. 1990. Degradation of newly synthesized apolipoprotein B-100 in a pre- Golgi compartment. J. Biol. Chem. 265: 11880–11884.
Sparks, J D., C E. Sparks, A. M. Roncone, And J. M. Amatruda. 1988. Secretion of high and low molecular weight phosphorylated apolipoprotein B by hepatocytes from control and diabetic rats. J. Biol. Chem. 263: 5001–5004.
Stoffel, W., E. Kruger, and R. DEutzmann 1983. Cell-free translation of human liver apolipoprotein A-I and A-II mRNA: processing of primary translation products. HoppeSeyler’s Z. Physiol. Chem. 364: 227–237.
Swaminathan, N., and F. Aladjem. 1976. The monosaccharide composition and sequence of the carbohydrate moiety of human serum low density lipoproteins. Biochemistry. 15: 1516–1522.
Wang, S.-Y., and D. L. Williams. 1982. Biosynthesis of vitellgenin: identification and characterization of non- phosphorylated precursors to avain vitellogenin I and vitellogenin II. J. Biol. Chem. 257: 3837–3846.
Woodgett, J. R., and T. Hunter. 1987. Isolation and characterization of two distinct forms of protein kinase C. J. Biol. Chem. 262: 4863–4843.
Yasuda, I., A. Kishimoto, S. Tanaka, M. Tominga, A. Sakurai, and Y. Nishizuka. 1990. A synthetic peptide substrate for selective assay of protein kinase C. Biochem. Biophys. Res. Commun. 166: 1220–1227.
Zannis, V.I., and J. L. Breslow. 1981 Human very low density lipopoprotein E isoprotein polymorphism is explained by genetic variation and post-translational modification. Biochemistry 20: 1033–1041
Zannis, V. I., S. K. Karathanasis, H. Keutmann, G. Goldberger, and J. L. Breslow. 1983. Intracellular and extracellular processing of human apolipoprotein A-I isoprotein 2 is a propeptide. Proc. Natl. Acad.Sci. USA 80: 2574–2578.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media New York
About this chapter
Cite this chapter
Beg, Z.H., Stonik, J.A., Hoeg, J.M., Brewer, H.B. (1995). Post-Translational Modification by Covalent Phosphorylation of Human Apolipoprotein B-100. In: Atassi, M.Z., Appella, E. (eds) Methods in Protein Structure Analysis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1031-8_31
Download citation
DOI: https://doi.org/10.1007/978-1-4899-1031-8_31
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-1033-2
Online ISBN: 978-1-4899-1031-8
eBook Packages: Springer Book Archive